The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma. - Wikidata - awgldk - TriplyDB

The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma.

The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma.

http://www.wikidata.org/entity/Q37686313

about

Human adipose tissue mesenchymal stromal cells and their extracellular vesicles act differentially on lung mechanics and inflammation in experimental allergic asthma.Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis.Establishment of preliminary regulatory network of TRPV1 and related cytokines.New approaches for identifying and testing potential new anti-asthma agents.Light-Emitting Diode treatment ameliorates allergic lung inflammation in experimental model of asthma induced by ovalbumin.Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma.The Cell Research Trends of Asthma: A Stem Frequency Analysis of the Literature

P2860

Q33830363-C719E9EB-9EA5-4C56-8C09-5DC4E453B81A Q37699569-BEF4E6FA-0EE0-4058-A321-7690587100C3 Q37728795-68C6C9C3-AF20-4913-89E4-B9562F31CF1E Q47873103-7A622D88-BA2A-44B7-9984-3B90CBAE3ED8 Q47917137-9AC6DC74-4A7E-4255-A24F-9FC9EB16466E Q55031358-B33C51BC-411D-4A87-BE21-18E832C6E8A3 Q57167816-9A592F22-3DCB-4E30-A2A4-81B634BD88DF

P2860

The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma.

http://www.wikidata.org/entity/Q37686313

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The tyrosine kinase inhibitor ...... experimental allergic asthma.

@en

The tyrosine kinase inhibitor ...... experimental allergic asthma.

@nl

type

label

The tyrosine kinase inhibitor ...... experimental allergic asthma.

@en

The tyrosine kinase inhibitor ...... experimental allergic asthma.

@nl

prefLabel

The tyrosine kinase inhibitor ...... experimental allergic asthma.

@en

The tyrosine kinase inhibitor ...... experimental allergic asthma.

@nl

P1433

Q37686313-D97D1695-F530-4022-8D07-F1C008855EB2

P1476

Q37686313-E85BC01F-C29C-4F2C-AA8C-228B5B1F6081

P2093

Q37686313-3E9EB180-A564-4D34-88B4-429EF3191FC4

Q37686313-4E038E58-3477-4D57-AC65-B404456041D9

Q37686313-5345DA11-45EC-4461-9281-3FBED575E05E

Q37686313-5B28DBD8-9239-4187-BE23-6E3A0E6709BA

Q37686313-6B9DE74B-3A48-48E2-9A44-5150DA835CCB

Q37686313-96D18B58-3D31-4668-931B-4F39C4605798

Q37686313-9E78C5F6-BA68-4AD7-9877-273C0633AAD2

Q37686313-D708926C-F473-48FC-9053-75AFBEC729EA

Q37686313-F35A1BAC-8B96-47B0-A711-979FAE280A79

P2860

Q37686313-02E69B9A-9CD7-4C49-B818-7E9C28CE636E

Q37686313-1614C594-9730-4E8D-8902-8CA09B459603

Q37686313-1FA27F3B-B631-4186-81B9-D567459B7055

Q37686313-221D7A41-FE4E-4EE7-B46A-330F819C353D

Q37686313-22BBB39C-0A37-470B-9DC8-FB3BBEE1015A

Q37686313-2C841DD0-0C89-4C93-A0DB-023F1E515621

Q37686313-2D8ECB3E-3862-40C0-8D25-AB0EC8EB39A1

Q37686313-31E86130-D7AE-4195-9FB7-0401D3EBA853

Q37686313-401D82DC-D204-4DD6-9827-3F8C1B7AC3F5

Q37686313-48B051DD-BCD5-4355-B219-9888B95A104B

P304

Q37686313-F148B1AF-8B1C-4714-A82F-C432A900FA25

P31

Q37686313-F53CE65F-89B0-4851-A534-191B09B1ECCD

P356

Q37686313-9EC62295-4792-4FCD-822F-C67FC66F94D7

P407

Q37686313-744AA4AB-A2FC-4575-A294-15E8B478F4FF

P433

Q37686313-BEDE645F-2499-49BE-89C6-CE25C375F679

P478

Q37686313-3C2BC492-A20E-41D9-B428-F86955A863F9

P50

Q37686313-63F2847B-4E79-4C75-864A-B022BD4E6E2D

Q37686313-BC523007-2310-42BB-BCB1-8CC2E1DCCA7B

P577

Q37686313-A3C2F122-40DD-4021-9521-072735CC4592

P698

Q37686313-9788C429-4BD4-477F-A803-985A54F04359

P921

Q37686313-DFDF5E31-6E35-4695-A43B-F09E97BD7371

Q37686313-ECC7118D-2F84-44A7-AF72-C60E0CC21FE8

P932

Q37686313-9EE3E181-0055-48B8-8C86-64679A1C0915

P356

P1433

British Journal of Pharmacology

P1476

The tyrosine kinase inhibitor ...... n experimental allergic asthma

@en

P2093

A L da Silva

http://www.w3.org/2001/XMLSchema#string

M A Martins

http://www.w3.org/2001/XMLSchema#string

M M Morales

http://www.w3.org/2001/XMLSchema#string

P C Olsen

http://www.w3.org/2001/XMLSchema#string

P R M Rocco

http://www.w3.org/2001/XMLSchema#string

P S Marques

http://www.w3.org/2001/XMLSchema#string

R F Magalhães

http://www.w3.org/2001/XMLSchema#string

T P T Ferreira

http://www.w3.org/2001/XMLSchema#string

V C Branco

http://www.w3.org/2001/XMLSchema#string

P2860

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

How variability in clinical phenotypes should guide research into disease mechanisms in asthma

Chronic inflammation and asthma.

Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Effects of bone marrow-derived mononuclear cells on airway and lung parenchyma remodeling in a murine model of chronic allergic inflammation.

Severe asthma: definition and mechanisms.

Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.

Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive chemicals.

Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics

P304

1236-1247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.13430

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P50

Johnatas D. Silva

Fernanda Ferreira Cruz

P577

2016-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26989986

http://www.w3.org/2001/XMLSchema#string

P921

P932

5341339

http://www.w3.org/2001/XMLSchema#string